Member Info for trader250

Agree. My other non-US share is #ORPH. Until we have a vaccine, ODX and ORPH will both do well.

Always get these two mixed up!

Admit I am late but I have focussed on Nasdaq where I have done very well so it was a case of opportunity cost. The contact is very real despite what you think. The comment I received was Covid 19 has been a life saver for the company (see the charts). I had not realised this person worked for Omega until recently but when he/she mentioned the company was in Alloa, the penny dropped. I also had a conversation with a private clinical waste company last week and as I say, am encouraged. I could not purchase £50k so had to drop to £30k on HL. Target is 135p for me

That's my £30k purchase just through. Have been watching this for a while. I know a couple of people connected with the company (one senior employee and an outside contactor). Of course no details other than that I am encouraged with its prospects and what I know and can see this one doing very well in Q4 and beyond.

No - especially when the Quiz Directors/family members have not bought.

Agree that this is going down. Sold a little while ago and will watch for now. Think we will see 7/8p soon. Prof Karol Sikora reckons 1/3rd had undetectable levels of antibodies after test. I doubt most cash strapped employers will want to spend cash on this test. The Covid-19 play is over.

Fair point. If there is a series of good news (via RNS) then, yes, I can see a rise. One still to watch.

Not really. It would send a signal to the market that he considers the fall (in SP) to be significantly overdone and he could justify his purchase on this basis.

What part of investing do you not understand? I advised getting out of this months ago. For those who need to get back up to 20p the SP will have to rise 460%. Massive dilution of shares means that 460% rise is going to be very hard indeed.

I am astonished JD did not purchase any shares at the placing given he sold £300k last October (at 20p). That's a red flag for sure.

Agee. I got in at 677 and happy to hold. I also like Superdry (was a holder many years ago) and think they will do well too.

I had intended to do this yesterday but that's me in earlier with £90k. I see ASOS doing well out of the lockdown and it's certainly cheap going forward in the medium term.

Of course I know all about closed periods. I have contacted BIDS IR requesting confirmation if they are currently in a CP. I await their reply...

The elephant in the room is that non of the directors are buying at 3p but were happy to sell at 20p. 2p indeed soon...

I see the SP has fallen past my initial prediction that this would fall to 6p. Given the current market and total lack of news, I have revised my target and set alert for 3.5p. I like the idea but not willing to dip in until (at the very least) I see some serious director buys at this level.

The US are now wising up to Covid-19. Moderna and Alpha pro Tech on a tear the last few days. We know that Remdesivir inhibits Covid-19 (in association with chloroquine in vitro). Face masks will be a winner for Alpha.

This is an algo...

There will be a placing given the cash burn (and that will doubtless be below the current SP). So much for JW tweeting BIDS would be a 10 bagger last April (SP then @14p).

I said I would wait for the results so all was as I expected. Nothing in the RNS gives me any confidence to invest even at 6p (still overvalued) and in the absence of any positive news in RNS form (no podcasts, LinkedIn posts etc) this will sink further. To reiterate, if BIDS really do have a unique USP, the likes of Sequoia and co would have been over BIDS like a rash and been bought out by now. So much for the "huge" December "£10 million deal" RNS which is now confirmed as likely to deliver minor revenues. Oh dear!

Quiz look a long way from being a half decent investment. My concern is the poor online sales. Retail is awful abd so risky just now and I wonder if the Ramzan family have the stomach to carry on (the family made millions following the IPO) and so far it appears none of them have re-invested at the current price (90%) down so hardly an endorsement. Still on watchlist for now.